AbCellera Biologics Inc vs AGNC Investment Corp — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while AGNC Investment Corp trades at $10.9 (market cap $12.91B). The key difference: AGNC Investment Corp is far larger — about 4.3× AbCellera Biologics Inc's market cap, and AGNC Investment Corp pays a 13.22% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AGNC | |
|---|---|---|
Market Cap | $2.99B | $12.91B |
Sector | Health | Financials |
52-Week High | $9.76 | $12.17 |
52-Week Low | $2.78 | $9.46 |
Enterprise Value | $2.58B | — |
Dividend Yield | — | 13.22% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
Read more on AGNC →